SHENKMAN CAPITAL MANAGEMENT INC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 54 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SHENKMAN CAPITAL MANAGEMENT INC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2016$14,321,000
+6.8%
11,891,000
-1.1%
1.10%
-3.7%
Q2 2016$13,415,000
-52.1%
12,025,000
-50.1%
1.15%
-55.8%
Q1 2016$28,030,000
+47.8%
24,099,000
+63.7%
2.60%
+37.3%
Q4 2015$18,959,000
-0.9%
14,717,000
+0.6%
1.89%
+2.5%
Q3 2015$19,122,000
-21.1%
14,632,000
-6.2%
1.84%
-20.9%
Q2 2015$24,224,000
-5.8%
15,597,000
-10.5%
2.33%
-18.8%
Q1 2015$25,704,000
+8.3%
17,422,000
-13.5%
2.87%
+9.1%
Q4 2014$23,724,000
+40.1%
20,148,000
+26.2%
2.63%
+37.0%
Q3 2014$16,929,000
+298.9%
15,970,000
+289.5%
1.92%
+283.4%
Q2 2014$4,244,0004,100,0000.50%
Other shareholders

There were no reported owners of BIOMARIN PHARMACEUTICAL INC in Q2 2015.

NameSharesValueWeighting ↓
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders